Showing results (1291-1300 of 1,512) with videos related to
Sort By:
Pageof 152
Journal of Breast Cancer|April 18, 2013
Efficacy of exemestane in korean patients with metastatic breast cancer after failure of nonsteroidal aromatase inhibitorsJune Koo Lee, Seock-Ah Im, Daewon Lee, et al.Genomics|February 26, 2013
Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatmentDonghui Huang, Dong-Wan Kim, Athanasios Kotsakis, et al.Thrombosis and Haemostasis|January 31, 2014
Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancerYun-Gyoo Lee, Inho Kim, Eunyoung Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2016
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases ActivityPeter Ballard, James W T Yates, Zhenfan Yang, et al.Lung Cancer (Amsterdam, Netherlands)|March 12, 2024
Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER studyDong-Wan Kim, Byoung Chul Cho, Krishna Pachipala, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 14, 2023
CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief ReportDong-Wan Kim, Sang-We Kim, D Ross Camidge, et al.Journal of Korean Medical Science|August 15, 2014
Impact of multimodality approach for patients with leptomeningeal metastases from solid tumorsJeanny Kwon, Eui Kyu Chie, Kyubo Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2018
Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung CancerYi-Long Wu, James Chih-Hsin Yang, Dong-Wan Kim, et al.Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|August 6, 2011
VEGF expression is related to good response and long progression-free survival in gastrointestinal stromal tumor patients treated with SunitinibYoungil Koh, Hee Eun Lee, Seock-Ah Im, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2017
Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung CancerSuresh S Ramalingam, James C-H Yang, Chee Khoon Lee, et al.Pageof 152